FRONTPRO*3CPR 25-50KG 136MG

Name
FRONTPRO CHEWABLE TABLETS FOR DOGS

Category
Ectoparasiticides for systemic use.

Active ingredients
Each chewable tablet contains the active ingredient. Chewable tablets for dogs 2–4 kg; afoxolaner: 11.3 mg. Chewable tablets for dogs >4–10 kg; afoxolaner: 28.3 mg. Chewable tablets for dogs >10–25 kg; afoxolaner: 68 mg. Chewable tablets for dogs >25–50 kg; afoxolaner: 136 mg. For a full list of excipients, see section 6.1.

Directions
Treatment of flea infestations (Ctenocephalides felis and C. canis) in dogs for at least 5 weeks. Treatment of tick infestations (Dermacentor reticulatus, Ixodes ricinus, Rhipicephalus sanguineus) in dogs. One treatment eliminates ticks for up to a month. To be exposed to the active ingredient, fleas and ticks must attach to the host and initiate a blood meal.

Dosage
For oral use. Dosage: The product should be administered at doses of 2.7 to 7 mg/kg of body weight as per the following schedule. Dog's body weight: 2-4 kg; dosage and number of chewable tablets to be administered; frontpro 11 mg: 1. Dog's body weight: >4-10 kg; dosage and number of chewable tablets to be administered; frontpro 28 mg: 1. Dog's body weight: >10-25 kg; dosage and number of chewable tablets to be administered; frontpro 68 mg: 1. Dog's body weight: >25-50 kg; dosage and number of chewable tablets to be administered; frontpro 136 mg: 1. For dogs weighing more than 50 kg, use an appropriate combination of chewable tablets with different/equal dosages. The tablets should not be divided. Administration method: The tablets are chewable and palatable to most dogs. The tablets can be administered with food if the dog does not accept them directly. Treatment schedule. Treatment of flea and tick infestations: For optimal control of flea and tick infestations, the product should be administered at monthly intervals during peak flea and/or tick infestation seasons, based on the local epidemiological situation.

Conservation
This veterinary medicinal product does not require any special storage conditions. Shelf life of the veterinary medicinal product as packaged for sale: 3 years.

Pregnancy and breastfeeding
Laboratory studies conducted in rats and rabbits have not revealed any teratogenic effects or any adverse effects on the reproductive capacity of males and females. The safety of the veterinary medicinal product during pregnancy and lactation or in breeding dogs has not been established. Consult a veterinarian before treatment during pregnancy and lactation or before use in breeding dogs.